Molecular Magnetic Resonance Imaging of the Genitourinary Tract: Recent Results and Future Directions

Magnetic Resonance Imaging Clinics of North America

Volumn 16, Issue 4, 2008, Pages 627-641

  Grenier, Nicolas ^a,b   Hauger, Olivier ^a,b   Eker, Omer ^b   Combe, Christian ^b   Couillaud, Frank ^a   Moonen, Chrit ^a  

^a UMR 5287   (France)

^b HÔPITAL PELLEGRIN   (France)

Author keywords

Gene expression; Kidney diseases; Macrophages; Molecular imaging; MR imaging; Stem cells

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID GADOLINIUM; CELL RECEPTOR; GADOLINIUM; MATRIX METALLOPROTEINASE; MYELOPEROXIDASE; PUROMYCIN; RADIOPHARMACEUTICAL AGENT; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

APOPTOSIS; BIOLUMINESCENCE; CELL ACTIVITY; CELL PROLIFERATION; CELL THERAPY; CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; DNA MODIFICATION; DRUG HALF LIFE; ENZYME ACTIVITY; ENZYME SYNTHESIS; FOLLOW UP; GENE EXPRESSION; GLOMERULONEPHRITIS; HIGH INTENSITY FOCUSED ULTRASOUND; KIDNEY; MACROPHAGE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOLECULAR IMAGING; MONOCYTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; RENAL GRAFT DYSFUNCTION; REVIEW; SIGNAL NOISE RATIO; UROGENITAL SYSTEM;

ADULT; CHILD; FORECASTING; HUMANS; KIDNEY DISEASES; MAGNETIC RESONANCE IMAGING; UROGENITAL SYSTEM; UROLOGIC DISEASES;

EID: 52949151968     PISSN: 10649689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mric.2008.07.004     Document Type: Review

References (69)

1. Szabo Z., Xia J., Mathews W.B., et al. Future direction of renal positron emission tomography. Semin Nucl Med 36 1 (2006) 36-50
2. Cattell V. Macrophages in acute glomerular inflammation. Kidney Int 45 4 (1994) 945-952
3. Grau V., Herbst B., and Steiniger B. Dynamics of monocytes/macrophages and T lymphocytes in acutely rejecting rat renal allografts. Cell Tissue Res 291 1 (1998) 117-126
4. Schreiner G.F., Harris K.P., Purkerson M.L., et al. Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int 34 4 (1988) 487-493
5. Erwig L.P., Kluth D.C., and Rees A.J. Macrophages in renal inflammation. Curr Opin Nephrol Hypertens 10 3 (2001) 341-347
6. Modo M., Hoehn M., and Bulte J.W. Cellular MR imaging. Mol Imaging 4 3 (2005) 143-164
7. Hauger O., Delalande C., Trillaud H., et al. MR imaging of intrarenal macrophage infiltration in an experimental model of nephrotic syndrome. Magn Reson Med 41 1 (1999) 156-162
8. Hauger O., Delalande C., Deminiere C., et al. Nephrotoxic nephritis and obstructive nephropathy: evaluation with MR imaging enhanced with ultrasmall superparamagnetic iron oxide-preliminary findings in a rat model. Radiology 217 3 (2000) 819-826
9. Hauger O, Delmas Y, Deminere C, et al. Assessment of phagocytic and nonphagocytic phenotypes of activated mesangial cells with experimental iron oxide-enhanced MR imaging. Presented at the International Society of Magnetic Resonance in Medicine, Honolulu, May 18-24, 2002.
10. Devarajan P. Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17 6 (2006) 1503-1520
11. Friedewald J.J., and Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 66 2 (2004) 486-491
12. Ysebaert D.K., De Greef K.E., Vercauteren S.R., et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 15 10 (2000) 1562-1574
13. Jo S.K., Hu X., Kobayashi H., et al. Detection of inflammation following renal ischemia by magnetic resonance imaging. Kidney Int 64 1 (2003) 43-51
14. Ye Q., Yang D., Williams M., et al. In vivo detection of acute rat renal allograft rejection by MRI with USPIO particles. Kidney Int 61 3 (2002) 1124-1135
15. Zhang Y., Dodd S.J., Hendrich K.S., et al. Magnetic resonance imaging detection of rat renal transplant rejection by monitoring macrophage infiltration. Kidney Int 58 3 (2000) 1300-1310
16. Beckmann N., Cannet C., Zurbruegg S., et al. Macrophage infiltration detected at MR imaging in rat kidney allografts: early marker of chronic rejection?. Radiology 240 3 (2006) 717-724
17. Beckmann N., Cannet C., Fringeli-Tanner M., et al. Macrophage labeling by SPIO as an early marker of allograft chronic rejection in a rat model of kidney transplantation. Magn Reson Med 49 3 (2003) 459-467
18. Hauger O., Grenier N., Deminere C., et al. USPIO-enhanced MR imaging of macrophage infiltration in native and transplanted kidneys: initial results in humans. Eur Radiol 17 11 (2007) 2898-2907
19. Gupta S., Verfaillie C., Chmielewski D., et al. A role for extrarenal cells in the regeneration following acute renal failure. Kidney Int 62 4 (2002) 1285-1290
20. Baksh D., Song L., and Tuan R.S. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 8 3 (2004) 301-316
21. Pittenger M.F., and Martin B.J. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 95 1 (2004) 9-20
22. Fang B., Shi M., Liao L., et al. Systemic infusion of FLK1(+) mesenchymal stem cells ameliorate carbon tetrachloride-induced liver fibrosis in mice. Transplantation 78 1 (2004) 83-88
23. Bacigalupo A. Mesenchymal stem cells and haematopoietic stem cell transplantation. Best Pract Res Clin Haematol 17 3 (2004) 387-399
24. Imasawa T., Utsunomiya Y., Kawamura T., et al. The potential of bone marrow-derived cells to differentiate to glomerular mesangial cells. J Am Soc Nephrol 12 7 (2001) 1401-1409
25. Ito T., Suzuki A., Imai E., et al. Bone marrow is a reservoir of repopulating mesangial cells during glomerular remodeling. J Am Soc Nephrol 12 12 (2001) 2625-2635
26. Lin F., Cordes K., Li L., et al. Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 14 5 (2003) 1188-1199
27. Bulte J.W., Zhang S., van Gelderen P., et al. Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. Proc Natl Acad Sci U S A 96 26 (1999) 15256-15261
28. Hoehn M., Kustermann E., Blunk J., et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A 99 25 (2002) 16267-16272
29. Kraitchman D.L., Heldman A.W., Atalar E., et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation 107 18 (2003) 2290-2293
30. Bos C., Delmas Y., Desmouliere A., et al. In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology 233 3 (2004) 781-789
31. Ittrich H., Lange C., Togel F., et al. In vivo magnetic resonance imaging of iron oxide-labeled, arterially-injected mesenchymal stem cells in kidneys of rats with acute ischemic kidney injury: detection and monitoring at 3T. J Magn Reson Imaging 25 6 (2007) 1179-1191
32. Hauger O., Frost E.E., Deminière C., et al. MR evaluation of the glomerular homing of magnetically labeled mesenchymal stem cells in a rat model of nephropathy. Radiology 238 1 (2006) 200-210
33. Louie A.Y., Huber M.M., Ahrens E.T., et al. In vivo visualization of gene expression using magnetic resonance imaging. Nat Biotechnol 18 3 (2000) 321-325
34. Moore A., Josephson L., Bhorade R.M., et al. Human transferrin receptor gene as a marker gene for MR imaging. Radiology 221 1 (2001) 244-250
35. Weissleder R., and Mahmood U. Molecular imaging. Radiology 219 2 (2001) 316-333
36. Rome C., Couillaud F., and Moonen C.T. Spatial and temporal control of expression of therapeutic genes using heat shock protein promoters. Methods 35 2 (2005) 188-198
37. Dreano M., Brochot J., Myers A., et al. High-level, heat-regulated synthesis of proteins in eukaryotic cells. Gene 49 1 (1986) 1-8
38. Quesson B., de Zwart J.A., and Moonen C.T. Magnetic resonance temperature imaging for guidance of thermotherapy. J Magn Reson Imaging 12 4 (2000) 525-533
39. Huang Q., Hu J.K., Lohr F., et al. Heat-induced gene expression as a novel targeted cancer gene therapy strategy. Cancer Res 60 13 (2000) 3435-3439
40. Smith R.C., Machluf M., Bromley P., et al. Spatial and temporal control of transgene expression through ultrasound-mediated induction of the heat shock protein 70B promoter in vivo. Hum Gene Ther 13 6 (2002) 697-706
41. Braiden V., Ohtsuru A., Kawashita Y., et al. Eradication of breast cancer xenografts by hyperthermic suicide gene therapy under the control of the heat shock protein promoter. Hum Gene Ther 11 18 (2000) 2453-2463
42. Silcox C.E., Smith R.C., King R., et al. MRI-guided ultrasonic heating allows spatial control of exogenous luciferase in canine prostate. Ultrasound Med Biol 31 7 (2005) 965-970
43. Letavernier B., Salomir R., Delmas Y., et al. Ultrasound induced expression of a heat-shock promoter-driven transgene delivered in the kidney by genetically modified mesenchymal stem cells. A feasibility study. In: Hynynen K., and Jolesz F. (Eds). MR-guided focused ultrasound surgery (2007), Taylor & Francis, New-York 171-179
44. Eker O, Quesson B, Frulio N, et al. In vivo visualization of an optical reporter gene expression transported by a cellular vector and locally activated by MRI-guided HIFU in rat kidney. Presented at the International Society of Magnetic Resonance in Medicine, Toronto, May 3-9, 2008.
45. de Senneville B.D., Mougenot C., Quesson B., et al. MR thermometry for monitoring tumor ablation. Eur Radiol 17 9 (2007) 2401-2410
46. Chaubet F., Bertholon I., Serfaty J.M., et al. A new macromolecular paramagnetic MR contrast agent binds to activated human platelets. Contrast Media Mol Imaging 2 4 (2007) 178-188
47. Reynolds P.R., Larkman D.J., Haskard D.O., et al. Detection of vascular expression of E-selectin in vivo with MR imaging. Radiology 241 2 (2006) 469-476
48. Nahrendorf M., Jaffer F.A., Kelly K.A., et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114 14 (2006) 1504-1511
49. Choi K.S., Kim S.H., Cai Q.Y., et al. Inflammation-specific T1 imaging using anti-intercellular adhesion molecule 1 antibody-conjugated gadolinium diethylenetriaminepentaacetic acid. Mol Imaging 6 2 (2007) 75-84
50. Daldrup-Link H.E., Meier R., Rudelius M., et al. In vivo tracking of genetically engineered, anti-HER2/neu directed natural killer cells to HER2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol 15 1 (2005) 4-13
51. Hricak H., Choyke P.L., Eberhardt S.C., et al. Imaging prostate cancer: a multidisciplinary perspective. Radiology 243 1 (2007) 28-53
52. Chang S.S. Overview of prostate-specific membrane antigen. Rev Urol 6 Suppl 10 (2004) S13-S18
53. Hinkle G.H., Burgers J.K., Neal C.E., et al. Multicenter radioimmunoscintigraphic evaluation of patients with prostate carcinoma using indium-111 capromab pendetide. Cancer 83 4 (1998) 739-747
54. Serda R.E., Adolphi N.L., Bisoffi M., et al. Targeting and cellular trafficking of magnetic nanoparticles for prostate cancer imaging. Mol Imaging 6 4 (2007) 277-288
55. Ortiz A., Justo P., Sanz A., et al. Targeting apoptosis in acute tubular injury. Biochem Pharmacol 66 8 (2003) 1589-1594
56. Rana A., Sathyanarayana P., and Lieberthal W. Role of apoptosis of renal tubular cells in acute renal failure: therapeutic implications. Apoptosis 6 1-2 (2001) 83-102
57. Hakumaki J.M., and Brindle K.M. Techniques: visualizing apoptosis using nuclear magnetic resonance. Trends Pharmacol Sci 24 3 (2003) 146-149
58. Hiller K.H., Waller C., Nahrendorf M., et al. Assessment of cardiovascular apoptosis in the isolated rat heart by magnetic resonance molecular imaging. Mol Imaging 5 2 (2006) 115-121
59. Zhao M., Beauregard D.A., Loizou L., et al. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent. Nat Med 7 11 (2001) 1241-1244
60. Catania J.M., Chen G., and Parrish A.R. Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 292 3 (2007) F905-F911
61. Caron A., Desrosiers R.R., and Beliveau R. Ischemia injury alters endothelial cell properties of kidney cortex: stimulation of MMP-9. Exp Cell Res 310 1 (2005) 105-116
62. Bolbrinker J., Markovic S., Wehland M., et al. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension. J Pharmacol Exp Ther 316 1 (2006) 8-16
63. McLennan S.V., Kelly D.J., Cox A.J., et al. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 45 2 (2002) 268-275
64. Lancelot E., Amirbekian V., Brigger I., et al. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach. Arterioscler Thromb Vasc Biol 28 3 (2008) 425-432
65. Lepage M., Dow W.C., Melchior M., et al. Noninvasive detection of matrix metalloproteinase activity in vivo using a novel magnetic resonance imaging contrast agent with a solubility switch. Mol Imaging 6 6 (2007) 393-403
66. Malle E., Buch T., and Grone H.J. Myeloperoxidase in kidney disease. Kidney Int 64 6 (2003) 1956-1967
67. Chen J.W., Querol Sans M., Bogdanov Jr. A., et al. Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates. Radiology 240 2 (2006) 473-481
68. Nahrendorf M., Sosnovik D., Chen J.W., et al. Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. Circulation 117 9 (2008) 1153-1160
69. Chen J.W., Breckwoldt M.O., Aikawa E., et al. Myeloperoxidase-targeted imaging of active inflammatory lesions in murine experimental autoimmune encephalomyelitis. Brain 131 Pt 4 (2008) 1123-1133